Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference48 articles.
1. van Gool K, Norman R, Delatycki MB, et al. Understanding the costs of care for cystic fibrosis: an analysis by age and health state. Value Health. 2013;16(2):345–55.
2. Cystic Fibrosis Australia. Cystic fibrosis in Australia 2014, 17th annual report. Australian Cystic Fibrosis Data Registry. 2016.
https://www.cysticfibrosis.org.au/getmedia/769b5fbd-8ae6-4822-9b16-d1a804b0cf78/CFA_DataRegistryReport_2014_Final.pdf.aspx
. Accessed 4 Dec 2017.
3. Cystic Fibrosis Australia. Collaborative Research Project. Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF). Available from:
http://shop.cysticfibrosis.org.au/act/collaborative-research-project/
. [Accessed 1 Jan 2018].
4. Cystic Fibrosis Australia. Living with CF.
http://shop.cysticfibrosis.org.au/nsw/living/
. Accessed 11 Jan 2018.
5. Tappenden P, Harnan S, Uttley L, Mildred M, Carroll C, Cantrell A. Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model. Health Technol Assess. 2013;17(56):v–xvii (1–181).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献